Estrogens, inflammation and cognition

Frontiers in Neuroendocrinology

Volumn 40, Issue , 2016, Pages 87-100

  Au, April ^a   Feher, Anita ^a   McPhee, Lucy ^a   Jessa, Ailya ^a   Oh, Soojin ^a   Einstein, Gillian ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cognition; Dementia; Estrogens; Hormone therapy; Inflammation; Neuroinflammation

Indexed keywords

ACETYLSALICYLIC ACID; BRCA1 PROTEIN; BRCA2 PROTEIN; C REACTIVE PROTEIN; CLAUDIN 5; CYCLOOXYGENASE 2 INHIBITOR; ESTRADIOL BENZOATE; ESTRADIOL VALERATE; ESTROGEN; FOLLITROPIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LUTEINIZING HORMONE; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTEIN BCL 2; RANTES; TESTOSTERONE; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITIVE DEFECT; DEMENTIA; EFFECT SIZE; ENZYME PHOSPHORYLATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FIRST TRIMESTER PREGNANCY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; HYDROSTATIC PRESSURE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; LONG TERM POTENTIATION; MEMORY CONSOLIDATION; MENOPAUSE; MILD COGNITIVE IMPAIRMENT; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OBSERVATIONAL STUDY; OVARIECTOMY; OVARY FOLLICLE ATRESIA; PLEIOTROPY; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REVIEW; SECOND TRIMESTER PREGNANCY; TH17 CELL; THIRD TRIMESTER PREGNANCY; UPREGULATION; VERBAL MEMORY; ANIMAL; BRAIN; MEMORY; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; COGNITION; ESTROGENS; HUMANS; INFLAMMATION; MEMORY; MENOPAUSE;

EID: 84959474557     PISSN: 00913022     EISSN: 10956808     Source Type: Journal    
DOI: 10.1016/j.yfrne.2016.01.002     Document Type: Review

References (194)

1. Abbott N.J., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53. 10.1038/nrn1824.
2. Abbassi-Ghanavati M., Greer L.G., Cunningham F.G. Pregnancy and laboratory studies: a reference table for clinicians. Obstet. Gynecol. 2009, 114:1326-1331. 10.1097/AOG.0b013e3181c2bde8.
3. Abu-Taha M., Rius C., Hermenegildo C., Noguera I., Cerda-Nicolas J.-M., Issekutz A.C., Jose P.J., Cortijo J., Morcillo E.J., Sanz M.-J. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J. Immunol. 2009, 183:1393-1402. 10.4049/jimmunol.0803157.
4. Acosta J.I., Mayer L., Talboom J.S., Tsang C.W.S., Smith C.J., Enders C.K., Bimonte-Nelson H.A. Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system. Endocrinology 2009, 150:4248-4259. 10.1210/en.2008-1802.
5. Al-Sahab B., Ardern C.I., Hamadeh M.J., Tamim H. Age at menarche in Canada: results from the National Longitudinal Survey of Children & Youth. BMC Public Health 2010, 10:736. 10.1186/1471-2458-10-736.
6. Altsteil L.D., Sperber K. Cytokines in Alzheimer's disease. Neuro-Psychoparmacol. Biol. Psychiat. 1991, 15:481-495.
7. Andersen K., Launer L.J., Dewey M.E., Letenneur L., Ott A., Copeland J.R.M., Dartigues J.-F., Kragh-Sorensen P., Baldereschi M., Brayne C., Lobo A., Martinez-Lage J.M., Stijnen T., Hofman A. Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. Neurology 1999, 53. 1992-1992. 10.1212/WNL.53.9.1992.
8. Anderson S.E., Must A. Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. J. Pediatr. 2005, 147:753-760. 10.1016/j.jpeds.2005.07.016.
9. Anthony J.C., Breitner J.C.S., Zandi P.P., Meyer M.R., Jurasova I., Norton M.C., Stone S.V. Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County Study. Neurology 2000, 54:2066-2071. on behalf of the Cache County Memory Study Group. 10.1212/WNL.54.11.2066.
10. Archer D.F., Sturdee D.W., Baber R., de Villiers T.J., Pines A., Freedman R.R., Gompel A., Hickey M., Hunter M.S., Lobo R.A., Lumsden M.A., MacLennan A.H., Maki P., Palacios S., Shah D., Villaseca P., Warren M. Menopausal hot flushes and night sweats: where are we now?. Climacteric 2011, 14:515-528. 10.3109/13697137.2011.608596.
11. Bake S., Sohrabji F. 17Beta-Estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. Endocrinology 2004, 145:5471-5475. 10.1210/en.2004-0984.
12. Banks W.A., Farr S.A., Morley J.E. Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation 2002, 10:319-327. 10.1159/000071472.
13. Banks W.A., Farr S.A., La Scola M.E., Morley J.E. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J. Pharmacol. Exp. Ther. 2001, 299:536-541.
14. Barbaglia G., Macià F., Comas M., Sala M., del Mar Vernet M., Casamitjana M., Castells X. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up. Menopause 2009, 16:1061-1064. 10.1097/gme.0b013e3181a02b44.
15. Bastin C., Salmon E. Early neuropsychological detection of Alzheimer's disease. Eur. J. Clin. Nutr. 2014, 68:1192-1199. 10.1038/ejcn.2014.176.
16. Bellino F.L., Wise P.M. Nonhuman primate models of menopause workshop. Biol. Reprod. 2003, 10.1095/biolreprod.102.005215.
17. Benedusi V., Meda C., Della Torre S., Monteleone G., Vegeto E., Maggi A. A lack of ovarian function increases neuroinflammation in aged mice. Endocrinology 2012, 153:2777-2788. 10.1210/en.2011-1925.
18. Berchtold N.C., Cribbs D.H., Coleman P.D., Rogers J., Head E., Kim R., Beach T., Miller C., Troncoso J., Trojanowski J.Q., Zielke H.R., Cotman C.W. Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc. Natl. Acad. Sci. USA 2008, 105:15605-15610. 10.1073/pnas.0806883105.
19. Berendsen H.H. Hot flushes and serotonin. Menopause Int. 2002, 8:30-34. 10.1258/136218002100321569.
20. Beery A.K., Zucker I. Sex bias in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 2011, 35:565-572. 10.1016/j.neubiorev.2010.07.002.
21. Blasko I., Stampfer-Kountchev M., Robatscher P., Veerhuis R., Eikelenboom P., Grubeck-Loebenstein B. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 2004, 3:169-176. 10.1111/j.1474-9728.2004.00101.x.
22. Bove R., Secor E., Chibnik L.B., Barnes L.L., Schneider J.A., Bennett D.A., De Jager P.L. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 2014, 82:222-229. 10.1212/WNL.0000000000000033.
23. Bowen R.L., Isley J.P., Atkinson R.L. An association of elevated serum gonadotropin concentrations and Alzheimer disease?. J. Neuroendocrinol. 2000, 12:351-354. 10.1046/j.1365-2826.2000.00461.x.
24. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259. 10.1007/BF00308809.
25. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993, 10:1089-1099. 10.1016/0896-6273(93)90057-X.
26. Breitner J.C.S. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging 1996, 17:789-794. 10.1016/0197-4580(96)00109-1.
27. Brown C.M., Mulcahey T.A., Filipek N.C., Wise P.M. Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta. Endocrinology 2010, 151:4916-4925. 10.1210/en.2010-0371.
28. Burek M., Arias-Loza P.A., Roewer N., Förster C.Y. Claudin-5 as a novel estrogen target in vascular endothelium. Arterioscler. Thromb. Vasc. Biol. 2010, 30:298-304. 10.1161/ATVBAHA.109.197582.
29. Burt D.B., Zembar M.J., Niederehe G. Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol. Bull. 1995, 117:285-305. 10.1037/0033-2909.117.2.285.
30. Butchart J., Birch B., Bassily R., Wolfe L., Holmes C. Male sex hormones and systemic inflammation in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2012, 27:1. 10.1097/WAD.0b013e318258cd63.
31. Cantatore F.P., Loverro G., Ingrosso A.M., Lacanna R., Sassanelli E., Selvaggi L., Carrozzo M. Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clin. Rheumatol. 1995, 14:157-160.
32. Castelo-Branco C., Figueras F., Sanjuan A., Vicente J.J., Martínez de Osaba M.J., Pons F., Balasch J., Vanrell J.A. Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: benefits to bone and analysis of factors associated with discontinuation. Menopause 1999, 6:307-311. 10.1097/00042192-199906040-00006.
33. Cenci S., Weitzmann M.N., Roggia C., Namba N., Novack D., Woodring J., Pacifici R. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-a. J. Clin. Invest. 2000, 106:1229-1237. 10.1172/JCI11066.
34. Chabbert Buffet N., Djakoure C., Maitre S.C., Bouchard P. Regulation of the human menstrual cycle. Front. Neuroendocrinol. 1998, 19:151-186. 10.1006/frne.1998.0167.
35. Chakravarti S., Collins W.P., Newton J.R., Oram D.H., Studd J.W. Endocrine changes and symptomatology after oophorectomy in premenopausal women. Br. J. Obstet. Gynaecol. 1977, 84:769-775.
36. Cioffi M., Esposito K., Vietri M.T., Gazzerro P., D'Auria A., Ardovino I., Puca G.A., Molinari A.M. Cytokine pattern in postmenopause. Maturitas 2002, 41:187-192. 10.1016/S0378-5122(01)00286-9.
37. Cipolla M.J., Godfrey J.A., Wiegman M.J. The effect of ovariectomy and estrogen on penetrating brain arterioles and blood-brain barrier permeability. Microcirculation 2009, 16:685-693. 10.3109/10739680903164131.
38. Clarke C.J., Hales A., Hunt A., Foxwell B.M. IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. Eur. J. Immunol. 1998, 28:1719-1726. 10.1002/(SICI)1521-4141(199805)28.
39. Constantinescu C.S., Farooqi N., O'Brien K., Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 2011, 164:1079-1106. 10.1111/j.1476-5381.2011.01302.x.
40. Cunningham C., Hennessy E. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research. Alzheimers. Res. Ther. 2015, 7:1-13. 10.1186/s13195-015-0117-2.
41. de Vries H.E., Blom-Roosemalen M.C.M., van Oosten M., de Boer A.G., van Berkel T.J.C., Breimer D.D., Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 1996, 64:37-43. 10.1016/0165-5728(95)00148-4.
42. Dinarello C.A. The interleukin-1 family: 10 years of discovery. FASEB J. 1994, 8:1314-1325. Retrieved from http://www.fasebj.org/content/8/15/1314.short.
43. Disanto G., Ramagopalan S.V. On the sex ratio of multiple sclerosis. Mult. Scler. J. 2013, 19:3-4. 10.1177/1352458512447594.
44. Economos A., Wright C.B., Moon Y.P., Rundek T., Rabbani L., Paik M.C., Sacco R.L., Elkind M.S.V. Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study. Neuroepidemiology 2013, 40:253-259. 10.1159/000343276.
45. Ekdahl C.T., Claasen J.-H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA 2003, 100:13632-13637. 10.1073/pnas.2234031100.
46. Ekdahl C.T., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009, 158:1021-1029. 10.1016/j.neuroscience.2008.06.052.
47. Evans M.J., Eckert A., Lai K., Adelman S.J., Harnish D.C. Reciprocal antagonism between estrogen receptor and NF-KB activity in vivo. Circ. Res. 2001, 89:823-830. 10.1161/hh2101.098543.
48. Farrag A.F., Khedr E.M., Abdel-Aleem H., Rageh T.A. Effect of surgical menopause on cognitive functions. Dement. Geriatr. Cogn. Disord. 2002, 13:193-198. 10.1159/000048652.
49. Faulkner D.L., Young C., Hutchins D., McCollam J.S. Patient noncompliance with hormone replacement therapy: a nationwide estimate using a large prescription claims database. Menopause 1998, 5:226-229.
50. Finch A.P.M., Lubinski J., Møller P., Singer C.F., Karlan B., Senter L., Rosen B., Maehle L., Ghadirian P., Cybulski C., Huzarski T., Eisen A., Foulkes W.D., Kim-Sing C., Ainsworth P., Tung N., Lynch H.T., Neuhausen S., Metcalfe K.A., Thompson I., Murphy J., Sun P., Narod S.A. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J. Clin. Oncol. 2014, 32:1547-1553. 10.1200/JCO.2013.53.2820.
51. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 2008, 8:737-744. 10.1038/nri2394.
52. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198. 10.1016/0022-3956(75)90026-6.
53. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 2000, 908:244-254. 10.1111/j.1749-6632.2000.tb06651.x.
54. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., Winblad B. Very old women at highest risk of dementia and Alzheimer's disease incidence data from the Kungsholmen Project, Stockholm. Neurology 1997, 48:132-138. 10.1212/WNL.48.1.132.
55. Fuh J.L., Wang S.J., Lee S.J., Lu S.R., Juang K.D. A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 2006, 53:447-453. 10.1016/j.maturitas.2005.07.009.
56. Furness S., Roberts H., Marjoribanks J., Lethaby A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst. Rev. 2012, 8:CD000402. 10.1002/14651858.CD000402.pub4.
57. Gameiro C.M., Romão F., Castelo-Branco C. Menopause and aging: changes in the immune system - a review. Maturitas 2010, 67:316-320. 10.1016/j.maturitas.2010.08.003.
58. Garay L.I., González Deniselle M.C., Brocca M.E., Lima A., Roig P., De Nicola A.F. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis. Neuroscience 2012, 226:40-50. 10.1016/j.neuroscience.2012.09.032.
59. Gong Q.-H., Wang Q., Pan L.-L., Liu X.-H., Huang H., Zhu Y.-Z. Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: a pro-inflammatory pathway in rats. Pharmacol. Biochem. Behav. 2010, 96:52-58. 10.1016/j.pbb.2010.04.006.
60. Goshen I., Yirmiya R. The role of pro-inflammatory cytokines in memory processes and neural plasticity. Psychoneuroimmunology 2007, 337-377. Elsevier Academic Press, Burlington. forth ed. R. Ader (Ed.).
61. Greendale G.A., Wight R.G., Huang M.-H., Avis N., Gold E.B., Joffe H., Seeman T., Vuge M., Karlamangla A.S. Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation. Am. J. Epidemiol. 2010, 171:1214-1224. 10.1093/aje/kwq067.
62. Hara Y., Park C.S., Janssen W.G.M., Roberts M.T., Morrison J.H., Rapp P.R. Synaptic correlates of memory and menopause in the hippocampal dentate gyrus in rhesus monkeys. Neurobiol. Aging 2012, 33:421.e17-421.e28. 10.1016/j.neurobiolaging.2010.09.014.
63. Hauss-Wegrzyniak B., Lynch M.A., Vraniak P.D., Wenk G.L. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp. Neurol. 2002, 176:336-341. 10.1006/exnr.2002.7966.
64. Hebert L.E., Weuve J., Scherr P.A., Evans D.A. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013, 80:1778-1783. 10.1212/WNL.0b013e31828726f5.
65. Henderson V.W., Popat R.A. Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions. Neuroscience 2011, 191:129-138. 10.1016/j.neuroscience.2011.05.059.
66. Henderson V.W., Sherwin B.B. Surgical versus natural menopause: cognitive issues. Menopause 2007, 14:572-579. 10.1097/gme.0b013e31803df49c.
67. Hickey M., Elliott J., Davison S.L. Hormone replacement therapy. BMJ 2012, 344. e763-e763. 10.1136/bmj.e763.
68. Hogervorst E., Williams J., Budge M., Barnetson L., Combrinck M., Smith A.D. Serum total testosterone is lower in men with Alzheimer's Disease. Neuroendocrinol. Lett. 2001, 22:163-168.
69. Hogervorst E., Williams J., Budge M., Riedel W., Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000, 101:485-512. 10.1016/S0306-4522(00)00410-3.
70. Imtiaz B., Tuppurainen M., Tiihonen M., Kivipelto M., Soininen H., Hartikainen S., Tolppanen A.-M. Oophorectomy, hysterectomy, and risk of Alzheimer's disease: a nationwide case-control study. J. Alzheimers Dis. 2014, 42:575-581. 10.3233/JAD-140336.
71. in't Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Stijnen T., Breteler M.M.B., Stricker B.H.C. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 2001, 345:1515-1521. 10.1056/NEJMoa010178.
72. Jansson L., Olsson T., Holmdahl R. Estrogen induces a potent suppression of experimental autoimmune encephalomyelities and collagen-induced arthritis in mice. J. Neuroimmunol. 1994, 53:203-207. 10.1016/0165-5728(94)90030-2.
73. Jefferson A.L., Massaro J.M., Beiser A.S., Seshadri S., Larson M.G., Wolf P.A., Au R., Benjamin E.J. Inflammatory markers and neuropsychological functioning: the Framingham Heart Study. Neuroepidemiology 2011, 37:21-30. 10.1159/000328864.
74. Jewett P.I., Gangnon R.E., Trentham-Dietz A., Sprague B.L. Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010. Obstet. Gynecol. 2014, 124:727-733. 10.1097/AOG.0000000000000469.
75. Judd H.L., Judd G.E., Lucas W.E., Yen S.S. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J. Clin Endocrinol. Metab. 1974, 39:1020-1024. 10.1210/jcem-39-6-1020.
76. Kalaitzidis D., Gilmore T.D. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab. 2005, 16:46-52. 10.1016/j.tem.2005.01.004.
77. Kalyan S., Hitchcock C.L., Pudek M., Prior J.C. Acute effects of premenopausal hysterectomy with bilateral oophorectomy on serum lipids, hormonal values, inflammatory markers, and metabolism. J. Gynecol. Surg. 2011, 27:9-15. 10.1089/gyn.2009.0098.
78. Kang J.H., Cook N., Manson J., Buring J.E., Grodstein F. Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ 2007, 334:987. 10.1136/bmj.39166.597836.BE.
79. Kang J.H., Grodstein F. Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women. Neurology 2003, 60:1591-1597. 10.1212/01.WNL.0000065980.33594.B7.
80. Keenan P.A., Ezzat W.H., Ginsburg K., Moore G.J. Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 2001, 26:577-590. 10.1016/S0306-4530(01)00013-0.
81. Kerchner G.A., Nicoll R.A. Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat. Rev. Neurosci. 2008, 9:813-825. 10.1038/nrn2501.
82. Kermath B.A., Gore A.C. Neuroendocrine control of the transition to reproductive senescence: lessons learned from the female rodent model. Neuroendocrinology 2012, 96:1-12. 10.1159/000335994.
83. Kinnavane L., Albasser M.M., Aggleton J.P. Advances in the behavioural testing and network imaging of rodent recognition memory. Behav. Brain Res. 2015, 285:67-78. 10.1016/j.bbr.2014.07.049.
84. Korn-Lubetzki I., Kahana E., Cooper G., Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Ann. Neurol. 1984, 16:229-231. 10.1002/ana.410180120.
85. Korse C.M., Bonfrer J.M.G., van Beurden M., Verheijen R.H.M., Rookus M.A. Estradiol and testosterone levels are lower after oophorectomy than after natural menopause. Tumor Biol. 2009, 30:37-42. 10.1159/000199449.
86. Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell. Immunol. 2015, 294:63-69. 10.1016/j.cellimm.2015.01.018.
87. Kumru S., Godekmerdan A., Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J. Reprod. Immunol. 2004, 63:31-38. 10.1016/j.jri.2004.02.001.
88. Lacreuse A., Herndon J.G., Moss M.B. Cognitive function in aged ovariectomized female rhesus monkeys. Behav. Neurosci. 2000, 114:506-513. 10.1037//0735-7044.114.3.506.
89. Lethaby A., Hogervorst E., Richards M., Yesufu A., Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst. Rev. 2008, 4:1-43. 10.1002/14651858.CD003122.pub2.
90. Lee J.W., Lee Y.K., Yuk D.Y., Choi D.Y., Ban S.B., Oh K.W., Hong J.T. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflammation 2008, 5:37. 10.1186/1742-2094-5-37.
91. Lee D.C., Rizer J., Selenica M.-L.B., Reid P., Kraft C., Johnson A., Blair L., Gordon M.N., Dickey C.A., Morgan D. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J. Neuroinflammation 2010, 7:56. 10.1186/1742-2094-7-56.
92. Liu S., Wu H., Gai Xue X.M., Wu J., Qin Y., Hou Y. Metabolic alteration of neuroactive steroids and protective effect of progesterone in Alzheimer's disease-like rats. Neural. Regen. Res. 2013, 8:2800-2810. 10.3969/j.issn.1673-5374.2013.30.002.
93. Longcope C., Franz C., Morello C., Baker R., Johnston C.C. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 1986, 8:189-196. 10.1016/0378-5122(86)90025-3.
94. Longcope C., Hunter R., Franz C. Steroid secretion by the postmenopausal ovary. Am. J. Obstet. Gynecol. 1980, 138:564-568. 10.1097/00006254-198104000-00017.
95. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis results of an international survey. Neurology 1996, 46:907-911. 10.1212/WNL.46.4.907.
96. Luetters C., Huang M.-H., Seeman T., Buckwalter G., Meyer P.M., Avis N.E., Sternfeld B., Johnston J.M., Greendale G.A. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the Study of Women's Health across the Nation (SWAN). J. Women's Heal. 2007, 16:331-344. 10.1089/jwh.2006.0057.
97. Maki P.M. Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause 2013, 20:695-709. 10.1097/gme.0b013e3182960cf8.
98. Maki P.M., Drogos L.L., Rubin L.H., Banuvar S., Shulman L.P., Geller S.E. Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 2008, 15:848-856. 10.1097/gme.0b013e31816d815e.Objective.
99. Mandell K.J., Parkos C.A. The JAM family of proteins. Adv. Drug Deliv. Rev. 2005, 57:857-867. 10.1016/j.addr.2005.01.005.
100. Maret A., Coudert J.D., Garidou L., Foucras G., Gourdy P., Krust A., Dupont S., Chambon P., Druet P., Bayard F., Guéry J.-C. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur. J. Immunol. 2003, 33:512-521. 10.1002/immu.200310027.
101. Marriott L.K., Hauss-Wegrzyniak B., Benton R.S., Vraniak P.D., Wenk G.L. Long-term estrogen therapy worsens the behavioral and neuropathological consequences of chronic brain inflammation. Behav. Neurosci. 2002, 116:902-911. 10.1037/0735-7044.116.5.902.
102. Matynia A., Kushner S.A., Silva A.J. Genetic approaches to molecular and cellular cognition: a focus on LTP and learning and memory. Annu. Rev. Genet. 2002, 36:687-720. 10.1146/annurev.genet.36.062802.091007.
103. Mayer L.P., Devine P.J., Dyer C.A., Hoyer P.B. The follicle-deplete mouse ovary produces androgen. Biol. Reprod. 2004, 71:130-138. 10.1095/biolreprod.103.016113.
104. McCarrey A.C., Resnick S.M. Postmenopausal hormone therapy and cognition. Horm. Behav. 2015, 10.1016/j.yhbeh.2015.04.018.
105. McGeer P.L., McGeer E.G. NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 2007, 28:639-647. 10.1016/j.neurobiolaging.2006.03.013.
106. McGeer P.L., McGeer E., Rogers J., Sibley J. Anti-inflammatory drugs and Alzheimer disease. Lancet 1990, 335:1037.
107. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996, 47:425-432. 10.1212/WNL.47.2.425.
108. McKinlay S.M., Jefferys M. The menopausal syndrome. J. Epidemiol. Community Heal. 1974, 28:108-115. 10.1136/jech.28.2.108.
109. Menze E.T., Esmat A., Tadros M.G., Abdel-Naim A.B., Khalifa A.E. Genistein improves 3-NPA-induced memory impairment in ovariectomized rats: impact of its antioxidant, anti-inflammatory and acetylcholinesterase modulatory properties. PLoS One 2015, 10:e0117223. 10.1371/journal.pone.0117223.
110. Miranda P., Williams C.L., Einstein G. Granule cells in aging rats are sexually dimorphic in their response to estradiol. J. Neurosci. 1999, 19:3316-3325.
111. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765. 10.1126/science.1088417.
112. Mrak R.E., Sheng J.G., Griffin W.S. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 1995, 26:816-823. 10.1016/0046-8177(95)90001-2.
113. Nelson J.F., Felicio L.S., Osterburg H.H., Finch C.E. Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol. Reprod. 1981, 24:784-794. 10.1095/biolreprod24.4.784.
114. Nott P.M., Franklin M., Armitage C., Gelder M.G. Hormonal changes and mood in the puerperium. Br. J. Psychiatry 1976, 128:379-383. 10.1192/bjp.128.4.379.
115. O'Leary O.F., Wu X., Castren E. Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling. Psychoneuroendocrinology 2009, 34:367-381. 10.1016/j.psyneuen.2008.09.015.
116. Offner H., Adlard K., Zamora A., Vandenbark A.A. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest. 2000, 105:1465-1472. 10.1172/JCI9213.
117. Oliphant S.S., Jones K.A., Wang L., Bunker C.H., Lowder J.L. Trends over time with commonly performed obstetric and gynecologic inpatient procedures. Obstet. Gynecol. 2010, 116:926-931. 10.1097/AOG.0b013e3181f38599.
118. O'Neill L.A.J., Kaltschmidt C. NF-KB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 1997, 20:252-258. 10.1016/S0166-2236(96)01035-1.
119. Overlie I., Moen M.H., Morkrid L., Skjaeraasen J.S., Holte A. The endocrine transition around menopause-a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet. Gynecol. Scand. 1999, 78:642-647. 10.1034/j.1600-0412.1999.780714.x.
120. Pacifici R., Brown C., Puscheck E., Friedrich E., Slatopolsky E., Maggio D., McCracken R., Avioli L.V. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA 1991, 88:5134-5138. 10.1073/pnas.88.12.5134.
121. Palacios S., Henderson V.W., Siseles N., Tan D., Villaseca P. Age of menopause and impact of climacteric symptoms by geographical region. Climacteric 2010, 13:419-428. 10.3109/13697137.2010.507886.
122. Perry V.H., Holmes C. Microglial priming in neurodegenerative disease. Nat. Rev. Neurol. 2014, 10:217-224. 10.1038/nrneurol.2014.38.
123. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Kokmen E., Tangelos E.G. Aging, memory, and mild cognitive impairment. Int. Psychogeriatr. 1997, 9(Suppl. 1):65-69. 10.1017/S1041610297004717.
124. Pettus E.H., Wright D.W., Stein D.G., Hoffman S.W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res. 2005, 1049:112-119. 10.1016/j.brainres.2005.05.004.
125. Pfeilschifter J., Köditz R., Pfohl M., Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 2002, 23:90-119. 10.1210/er.23.1.90.
126. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992, 17:485-495. 10.1016/0306-4530(92)90007-T.
127. Phung T.K.T., Waltoft B.L., Laursen T.M., Settnes A., Kessing L.V., Mortensen P.B., Waldemar G. Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement. Geriatr. Cogn. Disord. 2010, 30:43-50. 10.1159/000314681.
128. Pourganji M., Hosseini M., Soukhtanloo M., Zabihi H., Hadjzadeh M.A.-R. Protective role of endogenous ovarian hormones against learning and memory impairments and brain tissues oxidative damage induced by lipopolysaccharide. Iran. Red Crescent Med. J. 2014, 16:e13954. 10.5812/ircmj.13954.
129. Prestwood K.M., Unson C., Kulldorff M., Cushman M. The effect of different doses of micronized 17beta-estradiol on C-reactive protein, interleukin-6, and lipids in older women. J. Gerontol. A. Biol. Sci. Med. Sci. 2004, 59:827-832. doi:59/8/M827.
130. Puder J.J., Freda P.U., Goland R.S., Wardlaw S.L. Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. J. Clin. Endocrinol. Metab. 2001, 86:2403-2408. 10.1210/jc.86.6.2403.
131. Pugh C.R., Kumagawa K., Fleshner M., Watkins L.R., Maier S.F., Rudy J.W. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain. Behav. Immun. 1998, 12:212-229. 10.1006/brbi.1998.0524.
132. Read M.D., Edey K.A., Hapeshi J., Foy C. Compliance with estrogen hormone replacement therapy after oophorectomy: a prospective study. Menopause Int. 2010, 16:60-64. 10.1258/mi.2010.010023.
133. Rebbeck T.R., Friebel T., Wagner T., Lynch H.T., Garber J.E., Daly M.B., Isaacs C., Olopade O.I., Neuhausen S.L., van 't Veer L., Eeles R., Evans D.G., Tomlinson G., Matloff E., Narod S.A., Eisen A., Domchek S., Armstrong K., Weber B.L. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J. Clin. Oncol. 2005, 23:7804-7810. 10.1200/JCO.2004.00.8151.
134. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., Granek I.A., Hogan P., Ockene J.K., Shumaker S.A. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J. Clin. Endocrinol. Metab. 2006, 91:1802-1810. 10.1210/jc.2005-2097.
135. Roberts J.A., Gilardi K.V., Lasley B., Rapp P.R. Reproductive senescence predicts cognitive decline in aged female monkeys. Neuroreport 1997, 8:2047-2051. 10.1097/00001756-199705260-00048.
136. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., Melton L.J. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007, 69:1074-1083. 10.1212/01.wnl.0000276984.19542.e6.
137. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., Melton L.J. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008, 70:200-209. 10.1212/01.wnl.0000280573.30975.6a.
138. Rocca W.A., Grossardt B.R., Shuster L.T. Oophorectomy, estrogen, and dementia: a 2014 update. Mol. Cell. Endocrinol. 2014, 389:7-12. 10.1016/j.mce.2014.01.020.
139. Rosario E.R. Age-related testosterone depletion and the development of Alzheimer disease. JAMA J. Am. Med. Assoc. 2004, 292:1431-1432. 10.1001/jama.292.12.1431-b.
140. Ross R.K., Paganini-Hill A., Wan P.C., Pike M.C. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. 2000, 92:328-332. 10.1093/jnci/92.4.328.
141. Ryan K.J. Biochemistry of aromatase: significance to female reproductive physiology. Cancer Res. 1982, 42:3342s-3344s.
142. Sales S., Ureshino R.P., Pereira R.T.D.S., Luna M.S.A., Pires de Oliveira M., Yamanouye N., Godinho R.O., Smaili S.S., Porto C.S., Abdalla F.M.F. Effects of 17β-estradiol replacement on the apoptotic effects caused by ovariectomy in the rat hippocampus. Life Sci. 2010, 86:832-838. 10.1016/j.lfs.2010.04.002.
143. Sandberg, K., Ji, H., Einstein, G., Au, A., Hay M., 2015. Is immune system related hypertension associated with ovarian hormone deficiency? Exp. Physiol. (in press). doi: . doi:10.1113/EP085149.
144. Sárvári M., Hrabovszky E., Kalló I., Solymosi N., Likó I., Berchtold N., Cotman C., Liposits Z. Menopause leads to elevated expression of macrophage-associated genes in the aging frontal cortex: rat and human studies identify strikingly similar changes. J. Neuroinflammation 2012, 9:264. 10.1186/1742-2094-9-264.
145. Scharbo-Dehaan M. Hormone replacement therapy. Nurse Pract. 1996, 21:1-13.
146. Scheff S.W., Price D.A., Schmitt F.A., Dekosky S.T., Mufson E.J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007, 68:1501-1508. 10.1212/01.wnl.0000260698.46517.8f.
147. Schram M.T., Euser S.M., de Craen A.J.M., Witteman J.C., Frölich M., Hofman A., Jolles J., Breteler M.M.B., Westendorp R.G.J. Systemic markers of inflammation and cognitive decline in old age. J. Am. Geriatr. Soc. 2007, 55:708-716. 10.1111/j.1532-5415.2007.01159.x.
148. Sherwin B.B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988, 13:345-357. 10.1016/0306-4530(88)90060-1.
149. Shors T., Matzel L. Long-term potentiation: what's learning got to do with it?. Behav. Brain Sci. 1997, 20:597-655.
150. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Morley Kotchen J., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA 2003, 289:2651. for the WHIMS Investigators. 10.1001/jama.289.20.2651.
151. Si D., Wang H., Wang Q., Zhang C., Sun J., Wang Z., Zhang Z., Zhang Y. Progesterone treatment improves cognitive outcome following experimental traumatic brain injury in rats. Neurosci. Lett. 2013, 553:18-23. 10.1016/j.neulet.2013.07.052.
152. Silva I., Mello L.E.A.M., Freymüller E., Haidar M.A., Baracat E.C. Onset of estrogen replacement has a critical effect on synaptic density of CA1 hippocampus in ovariectomized adult rats. Menopause 2003, 10:406-411. 10.1097/01.GME.0000064816.74043.E9.
153. Singh M., Meyer E.M., Millard W.J., Simpkins J.W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 1994, 644:305-312. 10.1016/0006-8993(94)91694-2.
154. Smith R., Studd J. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J. R. Soc. Med. 1992, 85:612-613. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1433038.
155. Sohrabji F. Guarding the blood-brain barrier: a role for estrogen in the etiology of neurodegenerative disease. Gene Expr. 2007, 13:311-319. 10.3727/000000006781510723.
156. Sparkman N.L., Martin L.A., Calvert W.S., Boehm G.W. Effects of intraperitoneal lipopolysaccharide on Morris maze performance in year-old and 2-month-old female C57BL/6J mice. Behav. Brain Res. 2005, 159:145-151. 10.1016/j.bbr.2004.10.011.
157. Springer L.N., Flaws J.A., Sipes I.G., Hoyer P.B. Follicular mechanisms associated with 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Reprod. Toxicol. 1996, 10:137-143. 10.1016/0890-6238(95)02056-X.
158. Stewart W.F., Kawas C., Corrada M., Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997, 48:626-632. 10.1212/WNL.48.3.626.
159. Störk S., von Schacky C., Angerer P. The effect of 17β-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial. Atherosclerosis 2002, 165:301-307. 10.1016/S0021-9150(02)00242-3.
160. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28:521-574. 10.1210/er.2007-0001.
161. Szekely C.A., Thorne J.E., Zandi P.P., Ek M., Messias E., Breitner J.C.S., Goodman S.N. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004, 23:159-169. 10.1159/000078501.
162. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580. 10.1002/ana.410300410.
163. Tierney M.C., Yao C., Kiss A., McDowell I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 2005, 64:1853-1859. 10.1212/01.WNL.0000163773.21794.0B.
164. Toniolo P., Koenig K.L., Pasternack B.S., Banerjee S., Rosenberg C., Shore R.E., Strax P., Levitz M. Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol. Biomarkers Prev. 1994, 3:47-50. Retrieved from http://cebp.aacrjournals.org/content/3/1/47.short.
165. Trollor J., Agars E. Systemic inflammation and cognition in the elderly. Neuropsychiatric Disorders 2010, 177-198. Springer, Tokyo. K. Miyoshi, Y. Moriumura, K. Maeda (Eds.).
166. Trollor J.N., Smith E., Baune B.T., Kochan N.A., Campbell L., Samaras K., Crawford J., Brodaty H., Sachdev P. Systemic inflammation is associated with MCI and its subtypes: the Sydney memory and aging study. Dement. Geriatr. Cogn. Disord. 2011, 30:569-578. 10.1159/000322092.
167. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 1999, 79:1-71. Retrieved from http://physrev.physiology.org/content/79/1/1.
168. van den Berg E., Kloppenborg R.P., Kessels R.P.C., Kappelle L.J., Biessels G.J. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim. Biophys. Acta - Mol. Basis Dis. 2009, 1792:470-481. 10.1016/j.bbadis.2008.09.004.
169. Vearncombe K.J., Pachana N.A. Is cognitive functioning detrimentally affected after early, induced menopause?. Menopause 2009, 16:188-198. 10.1097/gme.0b013e3181775eb4.
170. Vegeto E., Belcredito S., Etteri S., Ghisletti S., Brusadelli A., Meda C., Krust A., Dupont S., Ciana P., Chambon P., Maggi A. Estrogen receptor-a mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. 2003, 100:9614-9619. 10.1073/pnas.1531957100.
171. Vegeto E., Bonincontro C., Pollio G., Sala A., Viappiani S., Nardi F., Brusadelli A., Viviani B., Ciana P., Maggi A. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 2001, 21:1809-1818.
172. Velázquez-Zamora D.A., González-Tapia D., González-Ramírez M.M., Flores-Soto M.E., Vázquez-Valls E., Cervantes M., González-Burgos I. Plastic changes in dendritic spines of hippocampal CA1 pyramidal neurons from ovariectomized rats after estradiol treatment. Brain Res. 2012, 1470:1-10. 10.1016/j.brainres.2012.06.012.
173. Vereker E., Campbell V., Roche E., McEntee E., Lynch M.A. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J. Biol. Chem. 2000, 275:26252-26258. 10.1074/jbc.M002226200.
174. Vittimberga F.J., Foley D.P., Meyers W.C., Callery M.P. Laparoscopic surgery and the systemic immune response. Ann Surg. 1998, 227:326-334.
175. Wallace M., Luine V., Arellanos A., Frankfurt M. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res. 2006, 1126:176-182. 10.1016/j.brainres.2006.07.064.
176. Weber M.T., Maki P.M., McDermott M.P. Cognition and mood in perimenopause: a systematic review and meta-analysis. J. Steroid Biochem. Mol. Biol. 2013, 1-9. 10.1016/j.jsbmb.2013.06.001.
177. Weber M.T., Rubin L.H., Maki P.M. Cognition in perimenopause: the effect of transition stage. Menopause 2014, 20:511-517. 10.1097/gme.0b013e31827655e5.
178. Weiderpass E., Adami H.O., Baron J.A., Magnusson C., Bergström R., Lindgren A., Correia N., Persson I. Risk of endometrial cancer following estrogen replacement with and without progestins. J. Natl. Cancer Inst. 1999, 91:1131-1137. 10.1093/jnci/91.13.1131.
179. Whiteman M.K., Hillis S.D., Jamieson D.J., Morrow B., Podgornik M.N., Brett K.M., Marchbanks P.A. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am. J. Obstet. Gynecol. 2008, 198(34):e1-7. 10.1016/j.ajog.2007.05.039.
180. Willard L.B., Hauss-Wegrzyniak B., Danysz W., Wenk G.L. The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Exp. Brain Res. 2000, 134:58-65. 10.1007/s002210000446.
181. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Böttner M. Minireview: neuroprotective effects of estrogen-new insights into mechanisms of action. Endocrinology 2011, 142:969-973. 10.1210/endo.142.3.8033#sthash.H11hcdhV.dpuf.
182. Woolley C.S. Acute effects of estrogen on neuronal physiology. Annu. Rev. Pharmacol. Toxicol. 2007, 47:657-680. 10.1146/annurev.pharmtox.47.120505.105219.
183. Woolley C.S., Weiland N.G., McEwen B.S., Schwartzkroin P.A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 1997, 17:1848-1859.
184. Woolley S., McEwen B.S. Estradiol regulates hippocampal dendritic spine density via an N-Methyl-D-aspartate receptor-dependent mechanism. J Neurosci 1994, 74:7680-7687.
185. Wright D.W., Kellermann A.L., Hertzberg V.S., Clark P.L., Frankel M., Goldstein F.C., Salomone J.P., Dent L.L., Harris O.A., Ander D.S., Lowery D.W., Patel M.M., Denson D.D., Gordon A.B., Wald M.M., Gupta S., Hoffman S.W., Stein D.G. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 2007, 49:391-402. 10.1016/j.annemergmed.2006.07.932.
186. Wright D.W., Yeatts S.D., Silbergleit R., Palesch Y.Y., Hertzberg V.S., Frankel M., Goldstein F.C., Caveney A.F., Howlett-Smith H., Bengelink E.M., Manley G.T., Merck L.H., Janis L.S., Barsan W.G. Very early administration of progesterone for acute traumatic brain injury. N. Engl. J. Med. 2014, 371:2457-2466. 10.1056/NEJMoa1404304.
187. Xiao G., Wei J., Yan W., Wang W., Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit. Care 2008, 12:R61. 10.1186/cc6887.
188. Yaffe K., Kanaya A., Lindquist K., Simonsick E.M., Harris T., Shorr R.I., Tylavsky F.A., Newman A.B. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004, 292:2237-2242. 10.1001/jama.292.18.2237.
189. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998, 279:688-695. 10.1001/jama.279.9.688.
190. Yasui T., Maegawa M., Tomita J., Miyatani Y., Yamada M., Uemura H., Matsuzaki T., Kuwahara A., Kamada M., Tsuchiya N., Yuzurihara M., Takeda S., Irahara M. Changes in serum cytokine concentrations during the menopausal transition. Maturitas 2007, 56:396-403. 10.1016/j.maturitas.2006.11.002.
191. Yates M.A., Li Y., Chlebeck P., Proctor T., Vandenbark A.A., Offner H. Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2010, 220:136-139. 10.1016/j.jneuroim.2010.01.013.
192. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain. Behav. Immun. 2011, 25:181-213. 10.1016/j.bbi.2010.10.015.
193. Zarifkar A., Choopani S., Ghasemi R., Naghdi N., Maghsoudi A.H., Maghsoudi N., Rastegar K., Moosavi M. Agmatine prevents LPS-induced spatial memory impairment and hippocampal apoptosis. Eur. J. Pharmacol. 2010, 634:84-88. 10.1016/j.ejphar.2010.02.029.
194. Zhou L., Fester L., Von Blittersdorff B., Hassu B., Nogens H., Prange-Kiel J., Jarry H., Wegscheider K., Rune G.M. Aromatase inhibitors induce spine synapse loss in the hippocampus of ovariectomized mice. Endocrinology 2010, 151:1153-1160. 10.1210/en.2009-0254.